Guillaume (Gill) DER MEGREDITCHIAN

QuotaTrip est le résultat d’une collaboration entre les fondateurs du célèbre guide de voyage Le Petit Futé et des entrepreneurs passionnés de nouvelles technologies. Avec 40 ans d’expérience dans le tourisme et après avoir sillonné la planète entière avec des agences locales, nous leur proposons un outil marketing innovant et performant. Du côté des voyageurs, Quotatrip est la solution simple et gratuite pour préparer un voyage sur mesure en bénéficiant des meilleurs prix. Voyagez sur mesure avec les meilleures agences locales ! --------------------------------------------------------------- QuotaTrip is the result of a collaboration between the founders of the famous travel guide Le Petit Futé and entrepreneurs passionate about new technologies. With 40 years of experience in tourism and having travelled the world with local agencies, we offer them an innovative and efficient marketing tool. For travellers, Quotatrip is the simple and free solution to prepare a tailor-made trip at the best prices. Travel tailor-made with the best local agencies!

Iconic collectibles embodied by the greatest athletes, sports legends and clubs.

Ziwig Biotech is a biotechnology company pioneering the analysis of salivary RNA and the application of artificial intelligence to biomolecular biology. At the crossroads of medicine, data science, and digital technology, Ziwig develops non-invasive tests and therapeutic biomarkers designed to transform the diagnosis and management of chronic diseases—particularly those affecting women. Its flagship innovation, Endotest®, is the first non-invasive and highly reliable saliva-based test for the diagnosis of endometriosis. This breakthrough innovation, multiple award-winner (Galien Prize, Tech For Future Award), exemplifies Ziwig’s ability to revolutionize women’s health through the convergence of biotechnology, artificial intelligence, and precision medicine. Ziwig operates at the heart of a rapidly evolving global health ecosystem, where universal access to diagnosis and prevention is a major challenge for equity and sustainability. Through its scientific and societal commitment, Ziwig contributes to building a more human, accessible, and universal precision medicine—serving patients, healthcare professionals, and the health systems of the future. 🌐 www.ziwig.com

QuotaTrip est le résultat d’une collaboration entre les fondateurs du célèbre guide de voyage Le Petit Futé et des entrepreneurs passionnés de nouvelles technologies. Avec 40 ans d’expérience dans le tourisme et après avoir sillonné la planète entière avec des agences locales, nous leur proposons un outil marketing innovant et performant. Du côté des voyageurs, Quotatrip est la solution simple et gratuite pour préparer un voyage sur mesure en bénéficiant des meilleurs prix. Voyagez sur mesure avec les meilleures agences locales ! --------------------------------------------------------------- QuotaTrip is the result of a collaboration between the founders of the famous travel guide Le Petit Futé and entrepreneurs passionate about new technologies. With 40 years of experience in tourism and having travelled the world with local agencies, we offer them an innovative and efficient marketing tool. For travellers, Quotatrip is the simple and free solution to prepare a tailor-made trip at the best prices. Travel tailor-made with the best local agencies!

Iconic collectibles embodied by the greatest athletes, sports legends and clubs.

Ziwig Biotech is a biotechnology company pioneering the analysis of salivary RNA and the application of artificial intelligence to biomolecular biology. At the crossroads of medicine, data science, and digital technology, Ziwig develops non-invasive tests and therapeutic biomarkers designed to transform the diagnosis and management of chronic diseases—particularly those affecting women. Its flagship innovation, Endotest®, is the first non-invasive and highly reliable saliva-based test for the diagnosis of endometriosis. This breakthrough innovation, multiple award-winner (Galien Prize, Tech For Future Award), exemplifies Ziwig’s ability to revolutionize women’s health through the convergence of biotechnology, artificial intelligence, and precision medicine. Ziwig operates at the heart of a rapidly evolving global health ecosystem, where universal access to diagnosis and prevention is a major challenge for equity and sustainability. Through its scientific and societal commitment, Ziwig contributes to building a more human, accessible, and universal precision medicine—serving patients, healthcare professionals, and the health systems of the future. 🌐 www.ziwig.com